Results 251 to 260 of about 37,162 (308)
Prescribing Tourism: Cultivating Positive Travel Experiences for Individuals With Health Conditions
International Journal of Tourism Research, Volume 28, Issue 2, March/April 2026.ABSTRACT Clinical evidence of tourism's health‐related benefits for people with health conditions is notably scarce. Prescribing tourism, wherein medical professionals recommend engaging in tourism activities to enhance overall health and well‐being, could offer unique insights into the tourism–health nexus.
Fangli Hu, Jun Wen, Sebastian Filep
wiley +1 more source
Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials. [PDF]
Schizophr BullWang D +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Second-Generation Antipsychotic–Induced Hypoglycemia
The Primary Care Companion For CNS Disorders, 2018Complaints of hypoglycemia resemble the sedative effect of antipsychotics. As such, clinicians may overlook hypoglycemia in patients with psychiatric disorders. Here, a case of hypoglycemia associated with hyperinsulinemia induced by quetiapine in a female patient with bipolar disorder is reported.
Tomonari, Fujita +6 more
openaire +2 more sources
Second‐generation antipsychotics and
Introduction: It has been known for some time that antipsychotic medications are associated with an increased risk of venous thromboembolism (VTE) though mechanism of action has not yet been elucidated. However, it is not known if there are certain antipsychotics that are more associated with VTE than others, and with over 26 million ...
openaire +2 more sources
Second-generation antipsychotics for anxiety disorders
Cochrane Database of Systematic Reviews, 2010Anxiety disorders are common and disabling conditions, with a lifetime prevalence of 17% in the general population. Due to high rates of treatment resistance, there is interest in new pharmacological treatment options such as second-generation antipsychotics.To evaluate the efficacy and tolerability of second-generation antipsychotics as monotherapy or
Anna M, Depping +3 more
openaire +2 more sources
Switching Between Second-Generation Antipsychotics
CNS Drugs, 2005The introduction of second-generation antipsychotics represents an important advance in the treatment of schizophrenia. Although these drugs are generally very effective, not all patients respond in the same way. Partial response with persistent positive and negative symptoms and residual symptoms may force physicians to change antipsychotic medication.
Monika, Edlinger +4 more
openaire +2 more sources
Second-Generation Antipsychotics and Pneumonia-Related Hospitalizations
The Primary Care Companion For CNS Disorders, 2020To compare the rate of hospitalizations for pneumonia in patients with a psychotic or bipolar disorder who were prescribed 1 of 4 second-generation antipsychotics prior to admission.This retrospective cohort study included patients who were medically admitted for pneumonia to a 2,059-bed academic medical center or its associated health system hospital.
Victoria R, Milano +5 more
openaire +2 more sources
Pharmacogenetics of Second-Generation Antipsychotics
Pharmacogenomics, 2014This review considers pharmacogenetics of the so called 'second-generation' antipsychotics. Findings for polymorphisms replicating in more than one study are emphasized and compared and contrasted with larger-scale candidate gene studies and genome-wide association study analyses.
openaire +2 more sources